Did it fall or was it pushed? The contribution of trends in established risk factors to the decline in premature coronary heart disease mortality in New Zealand

Australian and New Zealand Journal of Public Health

Volumn 32, Issue 2, 2008, Pages 117-125

  Tobias, Martin ^a   Taylor, Richard ^b   Yeh, Li Chia ^a   Huang, Ken ^a   Mann, Stewart ^c   Sharpe, Norman ^d  

^a MINISTRY OF HEALTH   (New Zealand)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF OTAGO   (New Zealand)

^d National Heart Foundation   (New Zealand)

Author keywords

Coronary heart disease; New Zealand; Risk factor

Indexed keywords

CHOLESTEROL;

ADULT; AGE DISTRIBUTION; ARTICLE; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HAZARD RATIO; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEW ZEALAND; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SYSTOLIC BLOOD PRESSURE;

ADULT; AGE FACTORS; CORONARY ARTERY DISEASE; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NUTRITIONAL STATUS; PREVALENCE; RISK FACTORS; RISK REDUCTION BEHAVIOR; SMOKING; TOBACCO SMOKE POLLUTION;

EID: 42549100036     PISSN: 13260200     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1753-6405.2008.00186.x     Document Type: Article

References (41)

1. Tobias M, Sexton K, Mann S, Sharpe N. How low can it go? Projecting ischaemic heart disease mortality in New Zealand to 2015. N Z Med J. 2006;119:1-13.
2. Hay DR. Cardiovascular Disease in New Zealand 2004. Auckland (NZ): Heart Foundation; 2004. Technical Report No.: 82.
3. Taylor R, Dobson A, Mirzaei M. Contribution of changes in risk factors to the decline of coronary heart disease mortality in Australia over three decades. Eur J Cardiovasc Prev Rehabil. 2006; 13:1-9.
4. Lawlor DA, Ebrahim S, Davey-Smith G. Sex matters: secular and geographic trends in sex differences in coronary heart disease mortality. BMJ. 2001;323:541-5.
5. Tobias M, Turley M, Paul S, Sexton K. Debunking the 'only 50%' myth: prevalence of established risk factors in New Zealanders with self-reported ischaemic heart disease. Aust N Z Public Health. 2005;29:405-11.
6. Ezzati M, Rodgers A, Murray C, Lopez A. Comparative Quantification of Health Risks. Geneva (CHE): World Health Organization; 2004.
7. Rose G. Strategy of Preventive Medicine. Oxford (UK): Oxford University Press; 2000.
8. Ministry of Health. Nutrition and the Burden of Disease. Wellington (NZ): Government of New Zealand; 2003.
9. Cherrington AD. Presidential address: Diabetes: past, present and future. Diabetes Care. 2006;29:2158-64.
10. Asia Pacific Cohort Studies Collaboration. Blood pressure indices and cardiovascular disease in the Asia-Pacific region: a pooled analysis. Hypertension. 2003;42:69-75.
11. Asia Pacific Cohort Studies Collaboration, The effects of diabetes on the risk of major cardiovascular diseases and death in the Asia pacific region. Diabetes Care. 2003;26:360-6.
12. WHO. Age Standardization of Rates: A New WHO Standard. Geneva (CHE): World Health Organization; 2000. GPE Discussion Paper No.: 31.
13. Metcalf P, Scragg R, Schaaf D, et al. Trends in major cardiovascular risk factors in Auckland, New Zealand: 1982 to 2002-2003. N Z Med J, 2006;119:1-16.
14. Nye ER, Paulin J, Russell DG. Blood pressure in a random sample of the New Zealand population. N Z Med J. 1992; 105:1-3.
15. Russell D, Parnell W, Wilson N, et al. NZ Food: NZ People. Key Results of the 1997 National Nutrition Survey. Wellington (NZ): Government of New Zealand; 1999.
16. Ministry of Health. Taking the Pulse: the 1996/97 New Zealand Health Survey. Wellington (NZ): The Ministry; 1999.
17. Ministry of Health. New Zealand Tobacco Use Survey 2006. Wellington (NZ): Government of New Zealand; 2007.
18. Asia Pacific Cohort Studies Collaboration. Blood pressure and cardiovascular disease in the Asia-Pacific region. J Hypertens. 2003;21:707-16.
19. Asia Pacific Cohort Studies Collaboration. Cholesterol, coronary heart disease and stroke in the Asia-Pacific region. Int J Epidemiol. 2003;32:563-72.
20. Ezzati M, Lopez AD. Tobacco. In Ezzati M, Rodgers A, Murray C, Lopez A, eds. Comparative Quantification of Health Risks. Geneva: World Health Organization; 2004.
21. Jackson R, Beaglehole R. Trends in dietary fat and cigarette smoking and the decline in coronary heart disease mortality in New Zealand. Int J Epidemiol. 1987;16:377-82.
22. Capewell S, Beaglehole R, Seddon M, et al. Explanation for the decline in coronary heart disease mortality rates in Auckland, New Zealand, between 1982 and 1993. Circulation. 2000;102:1511-16.
23. Dobson AJ, McElduff P, Heller R, Alexander H, et al. Changing patterns of coronary heart disease in the Hunter region of New South Wales. J Clin Epidemiol. 1999;52:761-71.
24. Capewell S, Morrison CE, McMurray JJ. Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994. Heart. 1999;81(4):380-6.
25. Critchley JA, Capewell S. Substantial potential for reductions in coronary heart disease mortality in the UK through changes in risk factor levels. J Epidemiol Community Health. 2003;57(4):243-7.
26. Unal B, Critchley JA, Capewell S. Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation. 2004;109(9):1101-7.
27. Ministry of Health. Tobacco Trends 2006. Wellington (CHE): Government of New Zealand; 2007.
28. Laugesen M, Swinburn B. New Zealand's tobacco control programme 1985-98. Tob Control. 2000;9:155-62.
29. Tobias M, Huang K. Tobacco consumption in New Zealand: why did it fall? Aust NZJ Public Health. 2007;31:344-47.
30. Bjartveit K, Tvendal A. Health consequences of smoking 1-4 cigarettes per day. Tob Control. 2005;14:315-20.
31. Ministry of Health. Food and Nutrition Monitoring Report 2006. Wellington (NZ): Government of New Zealand; 2006.
32. Scientific Advisory Committee on Nutrition. Salt and Health. London (UK): The Stationery Office; 2003.
33. Young L, Swinburn B. Impact ofthe Pick the Tick food information programme on the salt content of food in New Zealand. Health Promot Int. 2002; 17:13-19.
34. Wald N, Law MR. A strategy to reduce cardiovascular disease by more than 80%. Br Med J 2003;326:1419-27.
35. Ministry of Health. Healthy Eating Healthy Action: A Strategic Plan. Wellington (NZ): Government of New Zealand; 2003.
36. Ford ES, Ajani UA, Croft JB, et al. Explaining the decrease in US deaths from coronary disease, 1980-2000. N Engl J Med 2007;356:2388-98.
37. Metcalfe S, Moodie P. More about cardiovascular disease and lipid management in New Zealand. N Z Med J 2002;115:1-9.
38. Moodie P, Dougherty S, Metcalfe S. PHARMAC and statins - getting the best population health gains. N Z Med J. 2006;119:1-3.
39. Mant J, Hicks N. Detecting differences in quality of care: the sensitivity of measures of process and outcome in treating acute myocardial infarction. Br Med J 1995;311:793-96.
40. Yusuf S. Two decades of progress in preventing vascular disease. Lancet. 2002;360:2-3.
41. Mayor S, Ebrahim S. Polypill will not change prevention of heart disease. Br Med J. 2004;329:589.